News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mento Steven J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
4
| Mento Steven J (President and CEO) has filed a Form 4 on Histogen Inc.|
Txns:
| Granted 158,055 options to buy
@ $0.95, valued at
$150.2k
Granted 55,532 options to buy
@ $0.95, valued at
$52.8k
Disposed/sold 18,892 options to buy
@ $0
Disposed/sold 7,582 options to buy
@ $0 |
|
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Mento Steven J (Interim President and CEO) has filed a Form 4 on Histogen Inc.|
Txns:
| Granted 151,642 options to buy
@ $0.2352, valued at
$35.7k
|
|
| 01/05/2022 |
4
| Mento Steven J (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 11/10/2021 |
4
| Mento Steven J (Interim President and CEO) has filed a Form 4 on Histogen Inc.|
Txns:
| Granted 377,830 options to buy
@ $0.729, valued at
$275.4k
Granted 228,395 restricted stock units
@ $0 |
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
4
| Mento Steven J (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $7, valued at
$70k
|
|
| 08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2020 |
4
| Mento Steven J (Director) has filed a Form 4 on Histogen Inc.|
Txns:
| Paid exercise price by delivering 31,428 shares
@ $0.56, valued at
$17.6k
Exercised 65,000 restricted stock units
@ $0 |
|
| 08/01/2019 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Disposed/sold 400,000 options to buy
@ $9.45, valued at
$3.8M
Disposed/sold 150,000 options to buy
@ $6.4, valued at
$960k
Disposed/sold 50,000 options to buy
@ $6.4, valued at
$320k
Disposed/sold 20,000 options to buy
@ $1.85, valued at
$37k
Disposed/sold 37,500 options to buy
@ $1.85, valued at
$69.4k
Disposed/sold 172,500 options to buy
@ $4.21, valued at
$726.2k
Disposed/sold 120,000 options to buy
@ $5.17, valued at
$620.4k
Disposed/sold 350,000 options to buy
@ $2, valued at
$700k
Granted 650,000 restricted stock units
@ $0 |
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2018 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 2,500 shares
@ $0
Granted 15,000 options to buy
@ $15.65, valued at
$234.8k
|
|
| 05/07/2018 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Exercised 60,000 options to buy
@ $0.99, valued at
$59.4k
|
|
| 04/04/2018 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 7,115 shares
@ $18.3933, valued at
$130.9k
Sold 100 shares
@ $18.9, valued at
$1.9k
Exercised 10,000 options to buy
@ $7.77, valued at
$77.7k
|
|
| 03/05/2018 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 9,433 shares
@ $23.2743, valued at
$219.5k
Exercised 5,000 options to buy
@ $6.41, valued at
$32.1k
Exercised 10,000 options to buy
@ $5.03, valued at
$50.3k
|
|
| 02/05/2018 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 11,520 shares
@ $20.5867, valued at
$237.2k
Exercised 5,000 options to buy
@ $6.41, valued at
$32.1k
Exercised 10,000 options to buy
@ $10.17, valued at
$101.7k
|
|
| 02/05/2018 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 120,000 options to buy
@ $5.17, valued at
$620.4k
|
|
| 06/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2017 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc. |
| 12/22/2016 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc. |
| 06/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2016 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 187,500 options to buy
@ $1.85, valued at
$346.9k
Granted 37,500 options to buy
@ $1.85, valued at
$69.4k
|
|
| 06/24/2015 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Exercised 10,000 options to buy
@ $11.44, valued at
$114.4k
|
|
| 03/06/2015 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Sold 6,501 shares
@ $18.2955, valued at
$118.9k
Exercised 10,000 options to buy
@ $4.54, valued at
$45.4k
|
|
| 02/25/2015 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc.|
Txns:
| Granted 150,000 options to buy
@ $6.4, valued at
$960k
Granted 50,000 options to buy
@ $6.4, valued at
$320k
|
|
| 12/15/2014 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Sold 6,354 shares
@ $15, valued at
$95.3k
Exercised 10,000 options to buy
@ $4.1, valued at
$41k
|
|
| 06/11/2014 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Sold 4,328 shares
@ $15, valued at
$64.9k
Exercised 5,834 options to buy
@ $7.28, valued at
$42.5k
|
|
| 04/23/2014 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 10,000 options to buy
@ $14.2, valued at
$142k
|
|
| 03/17/2014 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Sold 6,103 shares
@ $22.7683, valued at
$139k
Exercised 9,722 options to buy
@ $3.87, valued at
$37.6k
|
|
| 02/11/2014 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc|
Txns:
| Granted 400,000 options to buy
@ $9.45, valued at
$3.8M
|
|
| 08/01/2013 |
4
| Mento Steven J (President, CEO & Director) has filed a Form 4 on Conatus Pharmaceuticals Inc|
Txns:
| Converted 95,323 shares
@ $0
Acquired 1,395 shares
@ $11, valued at
$15.3k
Bought 13,800 shares
@ $11, valued at
$151.8k
Converted 786,417 preferred shares
@ $0 |
|
| 06/14/2013 |
4
| Mento Steven J (Director) has filed a Form 4 on SANGAMO BIOSCIENCES INC|
Txns:
| Granted 10,000 options to buy
@ $7.77, valued at
$77.7k
|
|
| 06/25/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|